As a result, inhibitory immune pathways and checkpoint molecules—such as PD-1, CTLA-4, TIM-3, and LAG-3—are often highly expressed on tumor-infiltrating lymphocytes, which further supports the development of an immunosuppressive tumor landscape. This evidence concerns the gene CTLA4 and neoplasm.